This HTML5 document contains 45 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02130/identifier/kegg-compound/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02130/identifier/pdb/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02130/identifier/pubchem-compound/
n8http://linked.opendata.cz/resource/drugbank/drug/DB02130/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02130/identifier/drugbank/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n16http://linked.opendata.cz/resource/drugbank/drug/DB02130/identifier/chemspider/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n15http://linked.opendata.cz/resource/drugbank/drug/DB02130/identifier/chebi/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02130
rdf:type
n3:Drug
n3:description
A flavoring agent. It is the intermediate product in the two-step bioconversion of ferulic acid to vanillin. (J Biotechnol 1996;50(2-3):107-13). [PubChem]
n3:group
experimental
owl:sameAs
n6:DB02130 n10:DB02130
dcterms:title
4-Hydroxy-3-Methoxybenzoate
adms:identifier
n8:46509049 n11:VNL n12:23199 n13:DB02130 n14:C06672 n15:30816 n16:21708
n3:IUPAC-Name
n4:271B408F-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4095-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4094-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4091-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4092-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4093-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B408D-363D-11E5-9242-09173F13E4C5 n4:271B40A5-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B408B-363D-11E5-9242-09173F13E4C5 n4:271B408E-363D-11E5-9242-09173F13E4C5 n4:271B40A7-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B408C-363D-11E5-9242-09173F13E4C5 n4:271B40A8-363D-11E5-9242-09173F13E4C5
n3:pKa
n4:271B40A9-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B409B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B409C-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4096-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4097-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4099-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4098-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B409A-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
121-34-6
n3:Bioavailability
n4:271B40A1-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B40A3-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B40A4-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B40A6-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B40A0-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B409F-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B40A2-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4090-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B409D-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B409E-363D-11E5-9242-09173F13E4C5